Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.
Novartis researchers aim to quash inflammation to treat chronic disease.
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Researchers race to put hydroxychloroquine to the test in a large study.
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
Ad hoc announcement pursuant to article 53 Listing Rules.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.